F071 Skin-environmental Interface: Dermatologic Challenges of Our Changing Climate and Environment
DESCRIPTION
Climate change is an existential threat. With greater intensity and frequency of extreme weather events, serious health consequences are occurring now and threaten future generations. Dermatologists are uniquely positioned to advocate for public health, educate patients on the cutaneous manifestations of climate change, and create innovative solutions for mitigation. This session will highlight how climate change and pollution influence infectious, inflammatory, and autoimmune skin diseases with attention to disproportionately affected populations. This forum will provide learners with knowledge of key health impacts, tools to build sustainable practices, and opportunities for advocacy and engagement.
LEARNING OBJECTIVES
Examine the scientific consensus on climate change and its impacts on cutaneous disease and the practice of dermatology.
Define the impacts of global warming, climate change, and pollution on cutaneous disease and recognize the vulnerable populations that are disproportionately affected by these
Implement strategies to reduce our professional carbon footprint and identify advocacy opportunities
SCHEDULE
3:30 PM
Overview of the Impacts of Climate of Change in Dermatology
Eva R. Parker, MD, FAAD
3:50 PM
Climate Impacts on Pediatric Skin Disease
Sarah Jane Coates, MD, FAAD
4:04 PM
Impacts of Climate Change and Air Pollution on Chronic Skin Disease
Alexandra P Charrow, MD, FAAD
4:18 PM
Impact of Climate Change in the Global South with a Focus on Pakistan
Aisha Sethi, MD, FAAD
4:32 PM
The Environmental Impact of Biologic Therapy
Tina Bhutani, MD, FAAD
4:46 PM
Mohs Surgical Waste
Zachary A. Zinn, MD, FAAD
5:00 PM
Where we’ve been and where we’re going in dermatology
Misha Rosenbach, MD, FAAD
5:15 PM
Q&A
DIRECTOR
Eva R. Parker, MD, FAAD
SPEAKERS
Tina Bhutani, MD, FAAD
Alexandra P Charrow, MD, FAAD
Sarah Jane Coates, MD, FAAD
Misha Rosenbach, MD, FAAD
Aisha Sethi, MD, FAAD
Zachary A. Zinn, MD, FAAD
DISCLOSURES
Tina Bhutani, MD, FAAD
AbbVie – Investigator(Grants/Research Funding); Amgen – Speaker(Honoraria); Arcutis Biotherapeutics – Speaker(Honoraria); Arcutis, Inc. – Advisory Board(Fees); ASLAN Pharmaceuticals – Data Safety Monitoring Board(Fees); Boehringer Ingelheim – Advisory Board(Fees); Bristol-Myers Squibb – Advisory Board(Fees); Castle Biosciences – Investigator(Grants/Research Funding); Celgene – Investigator(Grants/Research Funding); Clementia Pharmaceuticals – Investigator(Grants/Research Funding); CoreEvitas, LLC – Investigator(Grants/Research Funding); Dermatology Foundation – Speaker(Honoraria); Dermavant Sciences – Investigator(Grants/Research Funding); Eli Lilly – Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Fees); FIDE – Consultant(Fees); Galderma – Speaker(Honoraria); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); Happify – Consultant(Fees); Janssen Biotech – Speaker(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Fees); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); LearnSkin – Speaker(Honoraria); LEO Pharma, US – Advisory Board(Fees); Mindera – Investigator(Grants/Research Funding); National Psoriasis Foundation – Speaker(Honoraria); Novartis – Advisory Board(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); Sun Pharmaceutical Industries Ltd. – Consultant(Fees); UCB – Advisory Board(Fees);
Alexandra P Charrow, MD, FAAD
Avalo – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(No Compensation Received); Novartis Pharmaceuticals Corp. – Advisory Board(Fees); Q32 Bio Inc. – Consultant (1099 relationship)(No Compensation Received); Sonoma Biotherapeutics – Investigator(No Compensation Received); UCB Pharma – Advisory Board(Honoraria); Wedbush Securities – Consultant (1099 relationship)(Honoraria);
Sarah Jane Coates, MD, FAAD
No financial relationships exist with ineligible companies.
Eva R. Parker, MD, FAAD
L'Oreal – Advisory Board(Honoraria), Speaker(Honoraria); Magellan Health – Consultant (1099 relationship)(Honoraria); Trend Sourcing – Consultant (1099 relationship)(Honoraria);
Misha Rosenbach, MD, FAAD
J&J Innovative Medicine – Consultant(Honoraria); Merck & Co., Inc – Consultant(Honoraria); Novartis – Consultant(Honoraria);
Aisha Sethi, MD, FAAD
No financial relationships exist with ineligible companies.
Zachary A. Zinn, MD, FAAD
No financial relationships exist with ineligible companies.